Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Another Biotech Bites the Dust as Cambridge's Raze Shuts Down

  • Post author:Sam
  • Post published:December 13, 2017
  • Post category:BioPharma

Reportedly, Raze Therapeutics, a biotech launched in 2014, has closed its doors. Source: BioSpace

Continue ReadingAnother Biotech Bites the Dust as Cambridge's Raze Shuts Down

Relay Therapeutics Lands $63M to Push Its Cancer Candidates Into Clinic

  • Post author:Sam
  • Post published:December 13, 2017
  • Post category:BioPharma

The round was led by BVF Partners, with new investors GV, Casdin Capital, EcoR1 Capital and Section 32. Source: BioSpace

Continue ReadingRelay Therapeutics Lands $63M to Push Its Cancer Candidates Into Clinic

Bristol-Myers Forks Over $40M Upfront for Another One of Ono Pharma's Cancer Prospects

  • Post author:Sam
  • Post published:December 13, 2017
  • Post category:BioPharma

The companies will also collaborate on discovery efforts to identify additional compounds from Ono’s PGE2 receptor antagonist programs. Source: BioSpace

Continue ReadingBristol-Myers Forks Over $40M Upfront for Another One of Ono Pharma's Cancer Prospects

Kyn Therapeutics Banks $49M to Advance Cancer Immunometabolism Therapies

  • Post author:Sam
  • Post published:December 13, 2017
  • Post category:BioPharma

Investors were Atlas Venture and OrbiMed. Source: BioSpace

Continue ReadingKyn Therapeutics Banks $49M to Advance Cancer Immunometabolism Therapies

argenx Bags $231M in Upsized U.S. IPO

  • Post author:Sam
  • Post published:December 13, 2017
  • Post category:BioPharma

argenx increased the Offering from the initially filed offering size of $150 million. Source: BioSpace

Continue Readingargenx Bags $231M in Upsized U.S. IPO

GRAIL Poaches New CEO From Roche, Genentech

  • Post author:Sam
  • Post published:December 13, 2017
  • Post category:BioPharma

Four months after Jeff Huber stepped down as CEO of GRAIL, the company has tapped his replacement. Source: BioSpace

Continue ReadingGRAIL Poaches New CEO From Roche, Genentech

This is the Drug That Could Kick Regeneron's Stock Into Gear

  • Post author:Sam
  • Post published:December 13, 2017
  • Post category:BioPharma

Regeneron shares have made little headway since the disappointing launch of Praluent in 2015. Source: BioSpace

Continue ReadingThis is the Drug That Could Kick Regeneron's Stock Into Gear

The Next Biotech 'Unicorn,' Ginkgo Bioworks, Just Nabbed Another $275M

  • Post author:Sam
  • Post published:December 13, 2017
  • Post category:BioPharma

Ginkgo Bioworks, recently recognized by Forbes as one of 25 U.S. companies likely to hit a valuation of $1B or more, is well on its way. Source: BioSpace

Continue ReadingThe Next Biotech 'Unicorn,' Ginkgo Bioworks, Just Nabbed Another $275M

Takeda Takes Stake, Inks Deal With Newly Launched Izana Bioscience

  • Post author:Sam
  • Post published:December 13, 2017
  • Post category:BioPharma

As part of the licence agreement, Takeda has taken a strategic equity stake in Izana. Source: BioSpace

Continue ReadingTakeda Takes Stake, Inks Deal With Newly Launched Izana Bioscience

Harpoon Medical's 16-Employee Office Will Stay Intact After Edwards Lifescience's $100M Acquisition

  • Post author:Sam
  • Post published:December 12, 2017
  • Post category:BioPharma

Harpoon's former CEO also hinted at possible growth at the office, including new hires for engineering and clinical team members. Source: BioSpace

Continue ReadingHarpoon Medical's 16-Employee Office Will Stay Intact After Edwards Lifescience's $100M Acquisition
  • Go to the previous page
  • 1
  • …
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • …
  • 288
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.